Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

D Holmberg

Showing results (211-220 of 305) with videos related to

Pageof 31
Sort By:
Journal of Acquired Immune Deficiency Syndromes (1999)|January 10, 2002
Use of highly active antiretroviral therapy in HIV-infected women: impact of HIV specialist careLytt I Gardner, Scott D Holmberg, Janet Moore, et al.
JAMA|February 19, 1988
Prior herpes simplex virus type 2 infection as a risk factor for HIV infectionS D Holmberg, J A Stewart, A R Gerber, et al.
Annals of Internal Medicine|April 16, 2003
Survival benefit of initiating antiretroviral therapy in HIV-infected persons in different CD4+ cell strataFrank J Palella, Maria Deloria-Knoll, Joan S Chmiel, et al.
HIV Medicine|January 27, 2005
Protease inhibitor exposure and increased risk of cardiovascular disease in HIV-infected patientsU H Iloeje, Y Yuan, G L'italien, et al.
Preventing Chronic Disease|January 26, 2013
Provider compliance with guidelines for management of cardiovascular risk in HIV-infected patientsKenneth A Lichtenstein, Carl Armon, Kate Buchacz, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 1, 2007
Initiation of antiretroviral therapy at CD4 cell counts >/=350 cells/mm3 does not increase incidence or risk of peripheral neuropathy, anemia, or renal insufficiencyKenneth A Lichtenstein, Carl Armon, Kate Buchacz, et al.
Drug and Alcohol Dependence|October 1, 1996
Crack cocaine smokers who turn to drug injection: characteristics, factors associated with injection, and implications for HIV transmission. The Multicenter Crack Cocaine and HIV Infection Study TeamK L Irwin, B R Edlin, S Faruque, et al.
Lancet (London, England)|June 13, 1992
Serum beta 2-microglobulin and prediction of progression to AIDS in HIV infectionA R Lifson, N A Hessol, S P Buchbinder, et al.
JAMA|February 12, 1998
Possible effectiveness of clarithromycin and rifabutin for cryptosporidiosis chemoprophylaxis in HIV disease. HIV Outpatient Study (HOPS) InvestigatorsS D Holmberg, A C Moorman, J C Von Bargen, et al.
AIDS (London, England)|April 26, 2000
Factors associated with the successful modification of antiretroviral therapy. HIV Outpatient Study InvestigatorsP J Weidle, K A Lichtenstein, A C Moorman, et al.
Pageof 31

Showing results (211-220 of 305) with videos related to

Sort By:
Pageof 31
Journal of Acquired Immune Deficiency Syndromes (1999)|January 10, 2002
Use of highly active antiretroviral therapy in HIV-infected women: impact of HIV specialist careLytt I Gardner, Scott D Holmberg, Janet Moore, et al.
JAMA|February 19, 1988
Prior herpes simplex virus type 2 infection as a risk factor for HIV infectionS D Holmberg, J A Stewart, A R Gerber, et al.
Annals of Internal Medicine|April 16, 2003
Survival benefit of initiating antiretroviral therapy in HIV-infected persons in different CD4+ cell strataFrank J Palella, Maria Deloria-Knoll, Joan S Chmiel, et al.
HIV Medicine|January 27, 2005
Protease inhibitor exposure and increased risk of cardiovascular disease in HIV-infected patientsU H Iloeje, Y Yuan, G L'italien, et al.
Preventing Chronic Disease|January 26, 2013
Provider compliance with guidelines for management of cardiovascular risk in HIV-infected patientsKenneth A Lichtenstein, Carl Armon, Kate Buchacz, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|November 1, 2007
Initiation of antiretroviral therapy at CD4 cell counts >/=350 cells/mm3 does not increase incidence or risk of peripheral neuropathy, anemia, or renal insufficiencyKenneth A Lichtenstein, Carl Armon, Kate Buchacz, et al.
Drug and Alcohol Dependence|October 1, 1996
Crack cocaine smokers who turn to drug injection: characteristics, factors associated with injection, and implications for HIV transmission. The Multicenter Crack Cocaine and HIV Infection Study TeamK L Irwin, B R Edlin, S Faruque, et al.
Lancet (London, England)|June 13, 1992
Serum beta 2-microglobulin and prediction of progression to AIDS in HIV infectionA R Lifson, N A Hessol, S P Buchbinder, et al.
JAMA|February 12, 1998
Possible effectiveness of clarithromycin and rifabutin for cryptosporidiosis chemoprophylaxis in HIV disease. HIV Outpatient Study (HOPS) InvestigatorsS D Holmberg, A C Moorman, J C Von Bargen, et al.
AIDS (London, England)|April 26, 2000
Factors associated with the successful modification of antiretroviral therapy. HIV Outpatient Study InvestigatorsP J Weidle, K A Lichtenstein, A C Moorman, et al.
Pageof 31